Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2019 1
2020 5
2021 10
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Effet d’un traitement par hydroxychloroquine prescrit comme traitement de fond de rhumatismes inflammatoires chroniques ou maladies auto-immunes systémiques sur les tests diagnostiques et l’évolution de l’infection à SARS CoV-2 : étude de 871 patients.
Trefond L, Drumez E, Andre M, Costedoat-Chalumeau N, Seror R, Devaux M, Dernis E, Dieudonne Y, El Mahou S, Lanteri A, Melki I, Queyrel V, Roumier M, Schmidt J, Barnetche T, Thomas T, Cacoub P, Belot A, Aumaitre O, Richez C, Hachulla E; FAI2R SFR SNFMI SOFREMIP CRI IMIDIATE consortium et contributeurs. Trefond L, et al. Among authors: roumier m. Rev Rhum Ed Fr. 2022 Mar;89(2):192-195. doi: 10.1016/j.rhum.2021.09.004. Epub 2021 Sep 29. Rev Rhum Ed Fr. 2022. PMID: 34602813 Free PMC article. French. No abstract available.
IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypes.
Moussiegt A, Müller R, Ebbo M, Grados A, Graveleau J, Ackermann F, Bachmeyer C, Bernit E, Blanche P, Canoui E, Chaix F, Costedoat-Chalumeau N, Groote P, Etienne N, Fior R, Flamarion E, Kennel T, Launay D, Lerolle N, Limal N, Loustau V, Menage E, Moulis G, Papo T, Pouchot J, Quemeneur T, Roumier M, Tchérakian C, Lefèvre G, Rebours V, Kahn JE, Schleinitz N, Groh M; CEREO; French IgG4-RD Study Group. Moussiegt A, et al. Among authors: roumier m. Autoimmun Rev. 2021 Sep;20(9):102889. doi: 10.1016/j.autrev.2021.102889. Epub 2021 Jul 5. Autoimmun Rev. 2021. PMID: 34237420 No abstract available.
CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME AND POSTERIOR OCULAR INVOLVEMENT: Case Series of 11 Patients and Literature Review.
Morel N, Bonnet C, Mehawej H, Le Guern V, Pérard L, Roumier M, Brezin A, Godeau B, Haroche J, Benhamou Y, Lambert M, Yelnik CM, Maillard N, Bodaghi B, Piette JC, Costedoat-Chalumeau N. Morel N, et al. Among authors: roumier m. Retina. 2021 Nov 1;41(11):2332-2341. doi: 10.1097/IAE.0000000000003185. Retina. 2021. PMID: 33840791 Review.
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
Danlos FX, Grajeda-Iglesias C, Durand S, Sauvat A, Roumier M, Cantin D, Colomba E, Rohmer J, Pommeret F, Baciarello G, Willekens C, Vasse M, Griscelli F, Fahrner JE, Goubet AG, Dubuisson A, Derosa L, Nirmalathasan N, Bredel D, Mouraud S, Pradon C, Stoclin A, Rozenberg F, Duchemin J, Jourdi G, Ellouze S, Levavasseur F, Albigès L, Soria JC, Barlesi F, Solary E, André F, Pène F, Ackerman F, Mouthon L, Zitvogel L, Marabelle A, Michot JM, Fontenay M, Kroemer G. Danlos FX, et al. Among authors: roumier m. Cell Death Dis. 2021 Mar 11;12(3):258. doi: 10.1038/s41419-021-03540-y. Cell Death Dis. 2021. PMID: 33707411 Free PMC article. Clinical Trial.
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants.
Chauvin C, Levillayer L, Roumier M, Nielly H, Roth C, Karnam A, Bonam SR, Bourgarit A, Dubost C, Bousquet A, Le Burel S, Mestiri R, Sene D, Galland J, Vasse M, Groh M, Le Marchand M, Vassord-Dang C, Gautier JF, Pham-Thi N, Verny C, Pitard B, Planchais C, Mouquet H, Paul R, Simon-Loriere E, Bayry J, Gilardin L, Sakuntabhai A. Chauvin C, et al. Among authors: roumier m. iScience. 2023 Mar 17;26(3):106124. doi: 10.1016/j.isci.2023.106124. Epub 2023 Feb 3. iScience. 2023. PMID: 36776936 Free PMC article.
High levels of TNFα in patients with COVID-19 refractory to tocilizumab.
Danlos FX, Ackermann F, Rohmer J, Roumier M, Marabelle A, Michot JM. Danlos FX, et al. Among authors: roumier m. Eur J Cancer. 2021 May;149:102-104. doi: 10.1016/j.ejca.2021.01.056. Epub 2021 Mar 20. Eur J Cancer. 2021. PMID: 33848711 Free PMC article. No abstract available.
CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.
Bernard-Valnet R, Moisset X, Maubeuge N, Lefebvre M, Ouallet JC, Roumier M, Lebrun-Frenay C, Ciron J, Biotti D, Clavelou P, Godeau B, Du Pasquier RA, Martin-Blondel G. Bernard-Valnet R, et al. Among authors: roumier m. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 2;9(1):e1097. doi: 10.1212/NXI.0000000000001097. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34728496 Free PMC article.
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.
Roumier M, Paule R, Vallée A, Rohmer J, Ballester M, Brun AL, Cerf C, Chabi ML, Chinet T, Colombier MA, Farfour E, Fourn E, Géri G, Khau D, Marroun I, Ponsoye M, Roux A, Salvator H, Schoindre Y, Si Larbi AG, Tchérakian C, Vasse M, Verrat A, Zuber B, Couderc LJ, Kahn JE, Groh M, Ackermann F; Foch COVID-19 Study Group. Roumier M, et al. J Clin Immunol. 2021 Feb;41(2):303-314. doi: 10.1007/s10875-020-00911-6. Epub 2020 Nov 14. J Clin Immunol. 2021. PMID: 33188624 Free PMC article.
A low level of CD16pos monocytes in SARS-CoV-2 infected patients is a marker of severity.
Vasse M, Zuber B, Goubeau L, Ballester MC, Roumier M, Delcominette F, Habarou F, Jolly E, Ackermann F, Cerf C, Farfour E, Pascreau T; SARS-CoV-2 Foch Hospital Study Group. Vasse M, et al. Among authors: roumier m. Clin Chem Lab Med. 2021 Feb 22;59(7):1315-1322. doi: 10.1515/cclm-2020-1801. Print 2021 Jun 25. Clin Chem Lab Med. 2021. PMID: 33606928 Free article.
19 results